𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck

✍ Scribed by Walter J. Koskinen; Ren Wei Chen; Ilmo Leivo; Antti Mäkitie; Leif Bäck; Risto Kontio; Riitta Suuronen; Christian Lindqvist; Eeva Auvinen; Anco Molijn; Wim G. Quint; Antti Vaheri; Leena-Maija Aaltonen


Publisher
John Wiley and Sons
Year
2003
Tongue
French
Weight
168 KB
Volume
107
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Fresh‐frozen biopsies were obtained from 61 patients at diagnosis of squamous cell carcinoma of the head and neck (HNSCC) for study of the prevalence and physical status of human papillomavirus (HPV) DNA. The frequency of HPV DNA and genotypes were determined by SPF10 PCR screening with a general probe hybridization and INNO‐LiPA HPV genotyping assay. In addition, a single‐phase PCR with primers FAP 59/64 and a nested PCR with primers CP 65/70 and CP 66/69 served to detect particularly cutaneous HPV types. By the sensitive SPF10 PCR and INNO‐LiPA assay, 37 of 61 (61%) samples were positive for HPV. HPV‐16 was the most frequently detected type (31 of 37, 84%). Multiple infections were found in 8 of 37 (22%) of the HPV‐positive samples, and co‐infection by HPV‐16 and HPV‐33 was predominant. No cutaneous HPV types were detected. Patients with HPV‐positive tumors had similar prognosis as those with HPV‐negative ones. Real‐time PCR analysis of the HPV‐16 positive samples indicated the presence of integrated (11 of 23, 48%), episomal (8 of 23, 35%) and mixed forms (4 of 23, 17%) of HPV DNA. The viral load of HPV DNA exhibited large variation. The median copy numbers of E6 DNA in tonsillar specimens were approximately 80,000 times higher than that in nontonsillar HNSCC ones. Patients with episomal viral DNA were more frequently found to have large (T3–T4) tumors at diagnosis than were those with integrated or mixed forms. © 2003 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Human papillomavirus 16 and head and nec
✍ C. Sloane Furniss; Michael D. McClean; Judith F. Smith; Janine Bryan; Heather H. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 101 KB 👁 1 views

## Abstract Evidence suggests that human papillomavirus (HPV)16 seropositivity reflects past HPV16 exposure and is associated with risk for head and neck squamous cell carcinoma (HNSCC). Our objectives were to test the hypothesis that HPV16 seropositivity is associated with risk for HNSCC, to corre

Histologic differentiation and chemosens
✍ Dr. Tadashi Nakashima; Drs. Yoshihiko Maehara; Shunji Kohnoe; Itsuroh Hayashi; Y 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 392 KB 👁 1 views

## Abstract The chemosensitivities of 42 human head and neck squamous cell carcinomas were examined using the in vitro succinate dehydrogenase inhibition (SDI) test. The tumor tissues obtained at surgery or biopsy were exposed to five different antitumor drugs: adriamycin (ADM), cisplatin (CDDP), c

Esophageal squamous cell cancer in patie
✍ Ethel-Michele de Villiers; Karin Gunst; Harald Stein; Hans Scherübl 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 75 KB 👁 2 views

## Abstract An etiologic role for human papillomavirus (HPV) infections in either head and neck (HNC) or esophageal carcinogenesis remains debatable. Patients with head and neck cancer are at high risk for developing a second esophageal squamous cell cancer (ESCC). The aim of our study was to deter

Prevalence and impact on clinicopatholog
✍ Daniel Weiss; Mario Koopmann; Claudia Rudack 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 327 KB 👁 1 views

## Abstract ## Background. Human papillomavirus (HPV) is a basic risk factor for head and neck squamous cell carcinoma (HNSCC). Little knowledge exists about the impact of HPV on clinical diagnostic and therapy of patients with HNSCC. ## Methods. We evaluated the evidence of HPV16 in 131 retrosp